PYC THERAPEUTICS LIMITED — Director's Dealing 2019

Apr 23, 2019

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PHYLOGICA LIMITED ABN 48 098 391 961

We, Phylogica Limited, give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Alan William Tribe
Date of last notice	30 November 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	INDIRECT
Nature of indirect interest	Mr Tribe is a Director of Australian Land Pty Ltd
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change	12 April 2019
**No. of securities held prior to change **	559,266,247 ordinary shares
Class	Ordinaryshares
Number acquired	300,000 ordinary shares
Nature of change	On-market trade
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Number disposed	Nil
Value/Consideration	$0.025 per ordinary share
Note: If consideration is non-cash, provide details and estimated valuation
**No. of securities held after change **	559,566,247 ordinary shares

• See chapter 19 for defined terms.

23/04/2019

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contractsdetailed above traded during a+closed period whereprior written clearance was required?	No
If so, was prior written clearance provided to allowthe trade to proceed during this period?
If prior written clearance was provided, on what datewas this provided?

• See chapter 19 for defined terms.

23/04/2019

Appendix 3Y Page 2